Uses and methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseases
US9273107B2 · kind B2 · utility
36Cited by
53References
63Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 26, 2013 |
| Grant date | Mar 1, 2016 |
| Priority date | — |
| Expiry date | Dec 26, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/68
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention relates to variants and fusions of fibroblast growth factor 19 (FGF19), variants and fusions of fibroblast growth factor 21 (FGF21), fusions of fibroblast growth factor 19 (FGF19) and/or fibroblast growth factor 21 (FGF21), and variants or fusions of fibroblast growth factor 19 (FGF19) and/or fibroblast growth factor 21 (FGF21) proteins and peptide sequences (and peptidomimetics), having one or more activities, such as bile acid homeostasis modulating activity, and methods for and uses in treatment of bile acid and other disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.